# TerrAscend Corp.: financial statements, quarterly

TSNDF · OTC · CIK 1778129 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tsndf.md) · [Financials](/companies/tsndf/financials.md) · [Filings](/companies/tsndf/filings.md) · [Insiders](/companies/tsndf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tsndf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [89.2](/filings/0000950170-24-122252.md) | [19.7 d](/filings/0001193125-26-104092.md) | [80.6](/filings/0000950170-25-066902.md) | [67.2](/filings/0000950170-25-104975.md) | [65.2](/filings/0001193125-25-268099.md) | [66.4 d](/filings/0001193125-26-104092.md) | [64.3](/filings/0001193125-26-210366.md) | [65.0](/filings/0001193125-26-337940.md) | [65.1](/filings/0001193125-25-268099.md) | [66.1 d](/filings/0001193125-26-104092.md) | [65.5](/filings/0001193125-26-210366.md) | [67.1](/filings/0001193125-26-337940.md) |
| Cost of revenue | $m | [41.4](/filings/0000950170-24-122252.md) | [(0.3) d](/filings/0001193125-26-104092.md) | [41.9](/filings/0000950170-25-066902.md) | [33.8](/filings/0000950170-25-104975.md) | [32.0](/filings/0001193125-25-268099.md) | [31.3 d](/filings/0001193125-26-104092.md) | [29.6](/filings/0001193125-26-210366.md) | [31.8](/filings/0001193125-26-337940.md) | [31.2](/filings/0001193125-25-268099.md) | [31.7 d](/filings/0001193125-26-104092.md) | [30.9](/filings/0001193125-26-210366.md) | [30.9](/filings/0001193125-26-337940.md) |
| Gross profit | $m | [47.8](/filings/0000950170-24-122252.md) | [20.1 d](/filings/0001193125-26-104092.md) | [38.7](/filings/0000950170-25-066902.md) | [33.4](/filings/0000950170-25-104975.md) | [33.2](/filings/0001193125-25-268099.md) | [35.1 d](/filings/0001193125-26-104092.md) | [34.7](/filings/0001193125-26-210366.md) | [33.2](/filings/0001193125-26-337940.md) | [33.9](/filings/0001193125-25-268099.md) | [34.5 d](/filings/0001193125-26-104092.md) | [34.6](/filings/0001193125-26-210366.md) | [36.3](/filings/0001193125-26-337940.md) |
| Selling, general and administrative | $m | [29.3](/filings/0000950170-23-061991.md) | [27.7 d](/filings/0000950170-24-031450.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [17.7](/filings/0000950170-24-122252.md) | [4.7 d](/filings/0001193125-26-104092.md) | [6.1](/filings/0000950170-25-066902.md) | [10.6](/filings/0000950170-25-104975.md) | [7.3](/filings/0001193125-25-268099.md) | [11.7 d](/filings/0001193125-26-104092.md) | [12.2](/filings/0001193125-26-210366.md) | [11.0](/filings/0001193125-26-337940.md) | [11.1](/filings/0001193125-25-268099.md) | [7.7 d](/filings/0001193125-26-104092.md) | [11.5](/filings/0001193125-26-210366.md) | [12.1](/filings/0001193125-26-337940.md) |
| Interest expense | $m | not reported | not reported | [7.1](/filings/0000950170-25-066902.md) | [7.0](/filings/0000950170-25-104975.md) | [6.9](/filings/0001193125-25-268099.md) | [7.0 d](/filings/0001193125-26-104092.md) | [6.7](/filings/0001193125-26-210366.md) | [7.0](/filings/0001193125-26-337940.md) | [7.4](/filings/0001193125-25-268099.md) | [7.7 d](/filings/0001193125-26-104092.md) | [7.4](/filings/0001193125-26-210366.md) | [7.2](/filings/0001193125-26-337940.md) |
| Income tax | $m | [13.5](/filings/0000950170-24-122252.md) | [(9.3) d](/filings/0001193125-26-104092.md) | [9.7](/filings/0000950170-25-066902.md) | [9.1](/filings/0000950170-25-104975.md) | [13.3](/filings/0001193125-25-268099.md) | [(4.9) d](/filings/0001193125-26-104092.md) | [10.5](/filings/0001193125-26-210366.md) | [9.6](/filings/0001193125-26-337940.md) | [11.0](/filings/0001193125-25-268099.md) | [(1.7) d](/filings/0001193125-26-104092.md) | [10.3](/filings/0001193125-26-210366.md) | [11.6](/filings/0001193125-26-337940.md) |
| Net income | $m | [(8.7)](/filings/0000950170-24-122252.md) | [(41.8) d](/filings/0001193125-26-104092.md) | [(14.9)](/filings/0001193125-25-268099.md) | [(6.2)](/filings/0001193125-25-268099.md) | [(21.4)](/filings/0001193125-25-268099.md) | [(30.2) d](/filings/0001193125-26-104092.md) | [(12.3)](/filings/0001193125-26-337940.md) | [(48.1)](/filings/0001193125-26-337940.md) | [(24.6)](/filings/0001193125-25-268099.md) | [3.6 d](/filings/0001193125-26-104092.md) | [(8.0)](/filings/0001193125-26-337940.md) | [(8.1)](/filings/0001193125-26-337940.md) |
| Diluted EPS | $ per share | [(0.04)](/filings/0000950170-24-122252.md) | not reported | [(0.06)](/filings/0000950170-25-066902.md) | [(0.03)](/filings/0000950170-25-104975.md) | [(0.08)](/filings/0001193125-25-268099.md) | not reported | [(0.05)](/filings/0001193125-26-210366.md) | [(0.17)](/filings/0001193125-26-337940.md) | [(0.08)](/filings/0001193125-25-268099.md) | not reported | [(0.03)](/filings/0001193125-26-210366.md) | [(0.03)](/filings/0001193125-26-337940.md) |
| Basic EPS | $ per share | [(0.04)](/filings/0000950170-24-122252.md) | not reported | [(0.06)](/filings/0000950170-25-066902.md) | [(0.03)](/filings/0000950170-25-104975.md) | [(0.08)](/filings/0001193125-25-268099.md) | not reported | [(0.05)](/filings/0001193125-26-210366.md) | [(0.17)](/filings/0001193125-26-337940.md) | [(0.08)](/filings/0001193125-25-268099.md) | not reported | [(0.03)](/filings/0001193125-26-210366.md) | [(0.03)](/filings/0001193125-26-337940.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [25.4](/filings/0000950170-23-061991.md) | [22.2](/filings/0000950170-25-034600.md) | [22.7](/filings/0000950170-24-056868.md) | [27.4](/filings/0000950170-24-093867.md) | [26.6](/filings/0000950170-24-122252.md) | [26.4](/filings/0001193125-26-104092.md) | [29.2](/filings/0000950170-25-066902.md) | [26.7](/filings/0000950170-25-104975.md) | [36.5](/filings/0001193125-25-268099.md) | [37.4](/filings/0001193125-26-337940.md) | [39.0](/filings/0001193125-26-210366.md) | [42.0](/filings/0001193125-26-337940.md) |
| Current assets | $m | [107](/filings/0000950170-23-061991.md) | [103](/filings/0000950170-25-034600.md) | [97.7](/filings/0000950170-24-056868.md) | [105](/filings/0000950170-24-093867.md) | [106](/filings/0000950170-24-122252.md) | [177](/filings/0001193125-26-104092.md) | [101](/filings/0000950170-25-066902.md) | [133](/filings/0000950170-25-104975.md) | [119](/filings/0001193125-25-268099.md) | [110](/filings/0001193125-26-337940.md) | [102](/filings/0001193125-26-210366.md) | [113](/filings/0001193125-26-337940.md) |
| Total assets | $m | [735](/filings/0000950170-23-061991.md) | [667](/filings/0000950170-25-034600.md) | [656](/filings/0000950170-24-056868.md) | [660](/filings/0000950170-24-093867.md) | [657](/filings/0000950170-24-122252.md) | [607](/filings/0001193125-26-104092.md) | [601](/filings/0000950170-25-066902.md) | [572](/filings/0000950170-25-104975.md) | [555](/filings/0001193125-25-268099.md) | [557](/filings/0001193125-26-337940.md) | [549](/filings/0001193125-26-210366.md) | [554](/filings/0001193125-26-337940.md) |
| Current liabilities | $m | [146](/filings/0000950170-23-061991.md) | [207](/filings/0000950170-25-034600.md) | [199](/filings/0000950170-24-056868.md) | [77.5](/filings/0000950170-24-093867.md) | [78.5](/filings/0000950170-24-122252.md) | [91.0](/filings/0001193125-26-104092.md) | [77.3](/filings/0000950170-25-066902.md) | [91.7](/filings/0000950170-25-104975.md) | [76.3](/filings/0001193125-25-268099.md) | [79.9](/filings/0001193125-26-337940.md) | [67.7](/filings/0001193125-26-210366.md) | [62.0](/filings/0001193125-26-337940.md) |
| Total liabilities | $m | [450](/filings/0000950170-23-061991.md) | [426](/filings/0000950170-25-034600.md) | [423](/filings/0000950170-24-056868.md) | [434](/filings/0000950170-24-093867.md) | [450](/filings/0000950170-24-122252.md) | [430](/filings/0001193125-26-104092.md) | [436](/filings/0000950170-25-066902.md) | [454](/filings/0000950170-25-104975.md) | [460](/filings/0001193125-25-268099.md) | [458](/filings/0001193125-26-337940.md) | [458](/filings/0001193125-26-210366.md) | [470](/filings/0001193125-26-337940.md) |
| Long-term debt | $m | [209](/filings/0000950170-23-061991.md) | [206](/filings/0000950170-25-034600.md) | [197](/filings/0000950170-24-056868.md) | [192](/filings/0000950170-24-093867.md) | [206](/filings/0000950170-24-122252.md) | [205](/filings/0001193125-26-104092.md) | [204](/filings/0000950170-25-066902.md) | [212](/filings/0000950170-25-104975.md) | [230](/filings/0001193125-25-268099.md) | [225](/filings/0001193125-26-337940.md) | [220](/filings/0001193125-26-210366.md) | [210](/filings/0001193125-26-337940.md) |
| Current portion of debt | $m | not reported | [126](/filings/0000950170-24-093867.md) | [125](/filings/0000950170-24-056868.md) | [9.7](/filings/0000950170-24-093867.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | [11.8](/filings/0000950170-25-034600.md) | [9.1](/filings/0000950170-24-056868.md) | [6.2](/filings/0000950170-24-093867.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [285](/filings/0000950170-24-122252.md) | [241](/filings/0001193125-26-104092.md) | [232](/filings/0001193125-25-268099.md) | [226](/filings/0001193125-25-268099.md) | [207](/filings/0001193125-25-268099.md) | [177](/filings/0001193125-26-337940.md) | [165](/filings/0001193125-26-337940.md) | [118](/filings/0001193125-26-337940.md) | [95.5](/filings/0001193125-25-268099.md) | [99.0](/filings/0001193125-26-337940.md) | [90.9](/filings/0001193125-26-337940.md) | [84.0](/filings/0001193125-26-337940.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [8.9 d](/filings/0000950170-24-122252.md) | [9.4 d](/filings/0001193125-26-104092.md) | [13.3](/filings/0000950170-25-066902.md) | [12.9 d](/filings/0000950170-25-104975.md) | [2.1 d](/filings/0001193125-25-268099.md) | [9.7 d](/filings/0001193125-26-104092.md) | [8.0](/filings/0001193125-26-210366.md) | [2.8 d](/filings/0001193125-26-337940.md) | [2.7 d](/filings/0001193125-25-268099.md) | [8.0 d](/filings/0001193125-26-104092.md) | [8.5](/filings/0001193125-26-210366.md) | [6.6 d](/filings/0001193125-26-337940.md) |
| Capital expenditure | $m | [1.7 d](/filings/0000950170-24-122252.md) | [(1.4) d](/filings/0001193125-26-104092.md) | [2.8](/filings/0000950170-25-066902.md) | [1.3 d](/filings/0000950170-25-104975.md) | [0.0 d](/filings/0001193125-25-268099.md) | [2.8 d](/filings/0001193125-26-104092.md) | [2.4](/filings/0001193125-26-210366.md) | [2.3 d](/filings/0001193125-26-337940.md) | [2.2 d](/filings/0001193125-25-268099.md) | [1.7 d](/filings/0001193125-26-104092.md) | [0.9](/filings/0001193125-26-210366.md) | [1.6 d](/filings/0001193125-26-337940.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | [0.1 d](/filings/0001193125-26-104092.md) | [0.2](/filings/0001193125-26-210366.md) | [0.1 d](/filings/0001193125-26-337940.md) | [0.0 d](/filings/0001193125-25-268099.md) | [0.0 d](/filings/0001193125-26-104092.md) | [0.1](/filings/0001193125-26-210366.md) | [0.3 d](/filings/0001193125-26-337940.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [254](/filings/0000950170-23-061991.md) | [267](/filings/0000950170-24-056868.md) | [275](/filings/0000950170-24-093867.md) | [287](/filings/0000950170-24-122252.md) | [291](/filings/0000950170-25-066902.md) | [291](/filings/0000950170-25-104975.md) | [292](/filings/0001193125-25-268099.md) | [293](/filings/0001193125-26-210366.md) | [299](/filings/0001193125-26-337940.md) | [306](/filings/0001193125-25-268099.md) | [309](/filings/0001193125-26-210366.md) | [309](/filings/0001193125-26-337940.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 309,175,647 at 2026-08-05, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-337940.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.